Table 2 Correlations between the tumor ADC values and aggressive characteristics.
Parameters | No. of patients (n) | Tumor ADC values (×10−3 mm2/s) | Spearman’s coefficient |
---|---|---|---|
Differentiation grade | |||
Poor | 11 (9.6%) | 0.89 ± 0.12 | 0.59** |
Moderate | 92 (80.0%) | 1.13 ± 0.25* | |
Good | 12 (10.4%) | 1.31 ± 0.19* | |
Clinical T stage | |||
T1 | 9 (7.8%) | 1.06 ± 0.08 | −0.08 |
T2 | 40 (34.8%) | 1.11 ± 0.20 | |
T3 | 53 (46.1%) | 1.03 ± 0.18 | |
T4 | 13 (11.3%) | 1.15 ± 0.18 | |
Plasma CEA level | |||
<5 ng/ml | 76 (66.1%) | 1.10 ± 0.25 | −0.07 |
≥5 ng/ml | 39 (33.9%) | 1.07 ± 0.19 |